Newsroom

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that management will be attending the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference at the Cliff Lodge in Snowbird, Utah. About Delcath Systems, Inc., HEPZATO KIT and CHEMOSAT Delcath Systems, Inc. is an interventional oncology company focused on the treatmen...

LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the amendment of its loan and security agreement with Hercules Capital, Inc. (NYSE:HTGC), strengthening its balance sheet and liquidity. Under the terms of the amended loan agreement, up to an additional $75 million will become available upon FDA’s approval of MOLBREEVI, the Company’s investigational therapy in autoimmune pul...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - February 26.01.2026 GFEB.LN IE000X8M8M80 650,002.00 USD 24,280,256.90 37.354  ...

LONDON--(BUSINESS WIRE)--Adaptive, the leader in custom trading technology solutions, today announced it is developing Aeron Sequencer, a software infrastructure platform designed to tackle the most persistent challenges in modern trading system development: consistency, scalability, performance, and availability. Delivering on these requirements demands niche expertise, large-scale investment, and extended delivery timelines. When done poorly, the consequences can be severe—from regulatory com...

ANN ARBOR, Mich.--(BUSINESS WIRE)--Customer satisfaction with the retail sector overall rises slightly in 2026, according to the American Customer Satisfaction Index....

NIAGARA FALLS, N.Y. & NEW ORLEANS--(BUSINESS WIRE)--Altera Digital Health, a global health IT leader, today announced the general availability of Sunrise™ Medical Photography powered by TRUE-See®, a suite of documentation tools within the Sunrise platform that produces color-calibrated medical photos and videos—critical for verifiably accurate assessment of wounds, dermatological issues, surgical sites and more. Leveraging TRUE-See’s proprietary technology, the solution is intended for use acro...

ARLINGTON, Mass.--(BUSINESS WIRE)--Maestra.io Ends 2025 with 5x US ARR Growth All-in-one ecommerce personalization platform grows US ARR +453% YoY...

PRINCETON, N.J. & TOKYO--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announce that the U.S. Food and Drug Administration (FDA) has accepted for priority review the New Drug Application (NDA) for centanafadine, an investigational, once-daily extended release capsule and the first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI), for the treatment of attention-deficit hyperactivity d...

CHICAGO--(BUSINESS WIRE)--Kira evolves to meet rising demands for speed, accuracy, and trusted GenAI in contract intelligence...

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), announced today that information regarding the federal income tax treatment of the dividends paid in 2025 on the Company's Common Stock and Series A Preferred Stock has been posted to the Company’s website, at the following link. https://investors.globalmedicalreit.com/stock-data/dividend-tax-information Note: Data for common dividends paid in January, April and July 2025 have been adjusted to refle...